This website uses cookies to enhance the user experience.
21st logo
||
I

INSULIFE AS925 128 554

Process industry
Limited company
Gaustadalléen 21 0349 OSLO, Norge

INSULIFE AS

Operating
Utvikle, eie, produsere, markedsføre og drive salg av spray baserte legemidler samt det som står i forbindelse med dette. Selskapet skal også kunne delta i andre virksomheter med økonomiske formål.

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Links

Organization

CEO
Chairman of the board
Years since formation
6 years
since Jun 5, 2020
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
71,748,834
1 share class
Total number of shareholders
731
126 companies, 605 persons

Financials

Total operating income 2025
59,500
NOK
Annual total result 2025
-13,955,309
NOK
Total equity 2025
10,116,159
NOK
Last update: Aug 20, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-
Board Member-
ResignedBoard Member-
ResignedBoard Member-
Board Member-

Others

NameRoleShares
B
BDO AS
Auditor-
V
VIEW GROUP AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
8.48 %
indirectly
-
3.04 %
directly 0.84 %
indirectly 2.2 %
-
2.74 %
indirectly
-
2.57 %
indirectly
-
2.2 %
indirectly
-
1.7 %
indirectly
-
1.4 %
directly
-
1.21 %
indirectly
Last update: Aug 20, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
P
PHARMAMENTOR AS
Ordinary shares
6,085,050
8.48 %
S
SCANPIPE ENGINEERING AS
Ordinary shares
2,359,000
3.29 %
S
SILVERCOIN INDUSTRIES AS
Ordinary shares
2,000,000
2.79 %
S
SKADI AS
Ordinary shares
1,966,650
2.74 %
3
3T HOLDING AS
Ordinary shares
1,580,200
2.2 %
Ordinary shares
1,219,512
1.7 %
Ordinary shares
1,003,666
1.4 %
K
KONSTRUKT HOLDING AS
Ordinary shares
865,000
1.21 %
C
CAMACA AS
Ordinary shares
716,650
1 %
L
LETRON AS
Ordinary shares
716,650
1 %
M
MOMENT HOLDING AS
Ordinary shares
609,700
0.85 %
Ordinary shares
600,350
0.84 %
Ordinary shares
500,000
0.7 %
V
VELU HOLDING AS
Ordinary shares
435,000
0.61 %
Ordinary shares
414,966
0.58 %
K
KN PROSJEKT AS
Ordinary shares
298,500
0.42 %
P
PE CONSULT & HOLDING AS
Ordinary shares
253,300
0.35 %
Ordinary shares
250,849
0.35 %
T
TORSEN TANKERS & TOWERS AS
Ordinary shares
250,000
0.35 %
T
TORFO AS
Ordinary shares
250,000
0.35 %
Ordinary shares
224,350
0.31 %
M
MEDI PARTNER HOLDING AS
Ordinary shares
200,000
0.28 %
Ordinary shares
183,333
0.26 %
G
GAUS CONSULT AS
Ordinary shares
180,000
0.25 %
Ordinary shares
170,000
0.24 %
S
SIRIUSUNGEN AS
Ordinary shares
166,650
0.23 %
M
MALO INVEST AS
Ordinary shares
166,650
0.23 %
Ordinary shares
165,000
0.23 %
C
CAKE AS
Ordinary shares
150,000
0.21 %
Ordinary shares
138,696
0.19 %
Ordinary shares
135,000
0.19 %
S
SOGN INVEST AS
Ordinary shares
133,350
0.19 %
T
TORJUSSEN CONSULTING AS
Ordinary shares
133,300
0.19 %
Ordinary shares
133,000
0.19 %
Ordinary shares
121,950
0.17 %
J
JAN CATO INVEST AS
Ordinary shares
121,649
0.17 %
S
SANNE INVESTMENTS AS
Ordinary shares
120,000
0.17 %
Ordinary shares
120,000
0.17 %
Ordinary shares
115,000
0.16 %
I
INGER MEDIA AS
Ordinary shares
101,529
0.14 %
Ordinary shares
100,000
0.14 %
Ordinary shares
100,000
0.14 %
Ordinary shares
100,000
0.14 %
Ordinary shares
100,000
0.14 %
F
FUNKSPORT AS
Ordinary shares
99,997
0.14 %
Ordinary shares
90,000
0.13 %
Ordinary shares
86,700
0.12 %
Ordinary shares
79,150
0.11 %
Ordinary shares
79,000
0.11 %
Ordinary shares
75,450
0.11 %
B
BUGAHEIA HOLDING AS
Ordinary shares
75,334
0.1 %
Ordinary shares
75,000
0.1 %
Ordinary shares
75,000
0.1 %
Ordinary shares
75,000
0.1 %
Ordinary shares
71,000
0.1 %
Ordinary shares
70,000
0.1 %
Ordinary shares
67,500
0.09 %
Ordinary shares
66,700
0.09 %
Ordinary shares
66,674
0.09 %
P
POPCORN AS
Closed
Ordinary shares
66,666
0.09 %
Ordinary shares
66,666
0.09 %
Ordinary shares
66,650
0.09 %
L
LEGE JØRN OTTO AHLQVIST AS
Ordinary shares
66,650
0.09 %
Ordinary shares
66,650
0.09 %
C
COGNUM AS
Ordinary shares
66,650
0.09 %
P
PABAK AS
Ordinary shares
66,650
0.09 %
Ordinary shares
65,500
0.09 %
Ordinary shares
60,000
0.08 %
T
TOM ODDEN AS
Ordinary shares
60,000
0.08 %
A
AS EKRE
Ordinary shares
60,000
0.08 %
S
SKYFRITT INVEST AS
Ordinary shares
60,000
0.08 %
Ordinary shares
58,600
0.08 %
Ordinary shares
55,000
0.08 %
Ordinary shares
55,000
0.08 %
Ordinary shares
53,556
0.07 %
T
TØNSBERG URSERVICE AS
Ordinary shares
53,333
0.07 %
Ø
Ø HOLDING AS
Ordinary shares
53,333
0.07 %
B
BOINCO AS
Ordinary shares
52,000
0.07 %
Ordinary shares
52,000
0.07 %
H
HUNEMO AS
Ordinary shares
51,666
0.07 %
Ordinary shares
50,166
0.07 %
V
VEDHAV AS
Ordinary shares
50,000
0.07 %
I
INTERPERSONELL AS
Ordinary shares
50,000
0.07 %
K
KLØKTIG INVEST AS
Ordinary shares
50,000
0.07 %
N
NORTH STAR INVESTMENTS AS
Ordinary shares
48,333
0.07 %
Ordinary shares
46,667
0.07 %
D
DAHLE GROUP AS
Ordinary shares
45,000
0.06 %
Ordinary shares
45,000
0.06 %
Ordinary shares
43,334
0.06 %
A
ANTEBELLUM INVEST AS
Ordinary shares
40,000
0.06 %
Ordinary shares
39,500
0.06 %
Ordinary shares
39,000
0.05 %
Ordinary shares
38,500
0.05 %
Ordinary shares
37,833
0.05 %
Ordinary shares
36,334
0.05 %
F
FREDHØI EIENDOM AS
Ordinary shares
35,000
0.05 %
Ordinary shares
35,000
0.05 %
Ordinary shares
33,865
0.05 %
Ordinary shares
33,334
0.05 %
Ordinary shares
33,334
0.05 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
59,500
56,000
0
0
0
Annual Total Result
-13,955,309
-12,896,816
-14,510,725
-8,668,014
-4,751,628
Total assets
27,445,518
28,665,236
29,125,131
31,438,082
11,340,518
Total liabilities
17,329,359
6,594,471
4,071,931
2,349,931
2,041,663
Total equity
10,116,159
22,070,765
25,053,200
29,088,151
9,298,855

P&L

Year20252024202320222021
Total operating income
59,500
56,000
0
0
0
Total operating costs
13,290,324
13,072,281
14,674,456
9,143,151
4,599,019
Operating result
-13,230,824
-13,016,281
-14,674,456
-9,143,151
-4,599,019
Financial income/costs
-724,485
119,464
163,731
475,138
-13,560
Profit before tax
-13,955,309
-12,896,816
-14,510,725
-8,668,014
-4,612,580
Total tax & extraordinary income/cost
0
0
0
0
139,048
Annual Total Result
-13,955,309
-12,896,816
-14,510,725
-8,668,014
-4,751,628

Balance overview

Year20252024202320222021
Total fixed assets
24,634,309
23,702,319
22,503,445
17,259,789
8,123,746
Total current assets
2,811,209
4,962,917
6,621,686
14,178,293
3,216,772
Total assets
27,445,518
28,665,236
29,125,131
31,438,082
11,340,518
Short term debt
10,498,141
5,616,565
2,581,808
1,754,950
2,041,663
Long term debt
0
977,906
1,490,122
594,981
0
Total liabilities
17,329,359
6,594,471
4,071,931
2,349,931
2,041,663
Contributed capital
10,116,159
22,070,765
53,430,925
42,955,150
14,497,841
Retained earnings
0
0
-28,377,724
-13,866,999
-5,198,986
Total equity
10,116,159
22,070,765
25,053,200
29,088,151
9,298,855
Total equity and liabilities
27,445,518
28,665,236
29,125,131
31,438,082
11,340,518

Classification

21st company classification
BETA
Scaleup
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations